Liver regeneration Journal of Hepatology

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Marcos Rojkind MD, Ph.D Professor of Biochemistry and Molecular Biology and Pathology Phone (202)
Elke Pogge von Strandmann, Silke Reinartz, Uwe Wager, Rolf Müller 
Inflammasomes in liver diseases
Alexander Loewer, Galit Lahav  Cell 
Angiogenesis and hepatocellular carcinoma
Myeloma cell interaction with extracellular matrix (ECM) and accessory cells in the marrow. Myeloma cells require support from bone marrow stromal cells.
Figure 3 Extracellular stimuli to HSC activation
Immunologic pathomechanism of Hodgkin's lymphoma
The yin and yang of evasion and immune activation in HCC
The inflammasome in liver disease
Carmen Peralta, Mónica B. Jiménez-Castro, Jordi Gracia-Sancho 
Obesity, inflammation, and liver cancer
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 47, Issue 1, Pages (July 2007)
Volume 52, Issue 3, Pages (March 2010)
Hedgehog signaling in the liver
Jean-Charles Nault, Jessica Zucman-Rossi  Journal of Hepatology 
Immunologic pathomechanism of Hodgkin's lymphoma
IL-6 pathway in the liver: From physiopathology to therapy
Aaron M. Abarbanell, MD, Arthur C. Coffey, MD, John W
Daniel A. Langer, Vijay H. Shah  Journal of Hepatology 
Volume 56, Issue 3, Pages (March 2012)
Regulatory T-cell directed therapies in liver diseases
Elke Pogge von Strandmann, Silke Reinartz, Uwe Wager, Rolf Müller 
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Volume 66, Issue 2, Pages (February 2017)
Volume 59, Issue 3, Pages (September 2013)
Craig H Selzman, MD, Stephanie A Miller, MD, Alden H Harken, MD 
Inflammation and portal hypertension – The undiscovered country
Volume 61, Issue 2, Pages (August 2014)
Regulatory T-cell directed therapies in liver diseases
Hepatitis C core protein – The “core” of immune deception?
Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions  Garrick K. Wilson, Daniel A. Tennant,
Signalling pathways in alcohol-induced liver inflammation
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Targeting gut flora to prevent progression of hepatocellular carcinoma
A. Craig Lockhart, Mace L. Rothenberg, Jordan D. Berlin 
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Angiogenesis and hepatocellular carcinoma
Opioids and neovascularization; pro or anti?
The yin and yang of evasion and immune activation in HCC
Volume 59, Issue 3, Pages (September 2013)
Sinusoidal communication in liver fibrosis and regeneration
Carmen Peralta, Mónica B. Jiménez-Castro, Jordi Gracia-Sancho 
Hepatic fibrosis: Concept to treatment
Volume 153, Issue 5, Pages (November 2017)
Volume 66, Issue 1, Pages (January 2017)
The key pathological mechanisms underlying vascular changes in pulmonary hypertension (PH). The key pathological mechanisms underlying vascular changes.
Reducing lipids for CV protection in CKD patients—current evidence
Targeting STAT3 in hepatocellular carcinoma: Sorafenib again…
Endothelial Cell Injury in Cardiovascular Surgery: The Systemic Inflammatory Response1  Edward M Boyle, MD, Timothy H Pohlman, MD, Marion C Johnson, MD,
Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer  Thomas Winder, Heinz–Josef.
Cannabinoid signaling and liver therapeutics
Volume 70, Issue 10, Pages (November 2006)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Death receptor-mediated apoptosis and the liver
Salvatore Papa, Concetta Bubici  Journal of Hepatology 
Therapeutic strategies in inflammasome mediated diseases of the liver
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Macrophage heterogeneity in liver injury and fibrosis
Figure 4 Bile-acid-induced TGR5 signalling pathways in macrophages
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Statins: Old drugs as new therapy for liver diseases?
Jinhua Tang, Na Liu, Shougang Zhuang  Kidney International 
Adel Hammoutene, Pierre-Emmanuel Rautou  Journal of Hepatology 
Foxa1 and Foxa2 regulate bile duct development in mice
Genetics of hepatocellular carcinoma: The next generation
Platelets arrive at the scene of fibrosis……studies
Presentation transcript:

Liver regeneration Journal of Hepatology Nelson Fausto, Jean S. Campbell, Kimberly J. Riehle  Journal of Hepatology  Volume 57, Issue 3, Pages 692-694 (September 2012) DOI: 10.1016/j.jhep.2012.04.016 Copyright © 2012 Terms and Conditions

Fig. 1 Liver regeneration from three different perspectives. (A) Hepatocyte proliferation after partial hepatectomy (PH). Depicted is the structure of the liver lobule, showing that zone 1 (periportal) hepatocytes divide during the first peak of DNA synthesis, whereas zone 2 hepatocytes comprise the second and third peaks of hepatocyte proliferation. (B) Key intracellular signaling pathways in hepatocytes after PH. (C) Hematogenous factors and intercellular interactions during liver regeneration, depicting signals between hepatocytes, Kupffer cells, T cells, hepatic stellate cells (HSC), liver sinusoidal endothelial cells (LSECs), and platelets. TGFα, transforming growth factor alpha; EGF, epidermal growth factor; HB-EGF, heparin binding EGF-like growth factor; AR, amphiregulin; EGFR, epidermal growth factor receptor; gp130, glycoprotein 130; HGF, hepatocyte growth factor; Met, receptor for hepatocyte growth factor; IL6, interleukin 6; IL6R, interleukin 6 receptor; ERK, extracellular related kinase; CAR, constitutive androgen receptor; NF-κB, nuclear factor kappa B; STAT3, signal transducer and activator of transcription 3; SOCS3, suppressor of cytokine signaling 3; TGFβ, transforming growth factor beta; TGFβR, transforming growth factor beta receptor; TGFα, transforming growth factor alpha; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor; NO, nitric oxide; LT, lymphotoxin; LPS, lipopolysaccaride. Journal of Hepatology 2012 57, 692-694DOI: (10.1016/j.jhep.2012.04.016) Copyright © 2012 Terms and Conditions